These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 28251495)
1. New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice. Girolami A; Cosi E; Ferrari S; Lombardi AM; Girolami B J Thromb Thrombolysis; 2017 Jul; 44(1):71-75. PubMed ID: 28251495 [TBL] [Abstract][Full Text] [Related]
2. New data on FII, FV, FIX and thrombomodulin defects: blood keeps clotting in normal and in peculiar ways. Girolami A; Ferrari S; Girolami B; Randi ML Hematology; 2019 Dec; 24(1):232-237. PubMed ID: 31793409 [No Abstract] [Full Text] [Related]
3. Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX). Girolami A; Ferrari S; Cosi E; Santarossa C; Randi ML Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):42S-47S. PubMed ID: 30428703 [TBL] [Abstract][Full Text] [Related]
4. Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis. Girolami A; Cosi E; Ferrari S; Girolami B Clin Appl Thromb Hemost; 2018 Sep; 24(6):845-849. PubMed ID: 29690772 [TBL] [Abstract][Full Text] [Related]
5. Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation. Girolami A; Cosi E; Ferrari S; Girolami B J Thromb Thrombolysis; 2018 Jan; 45(1):135-141. PubMed ID: 29063359 [TBL] [Abstract][Full Text] [Related]
8. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Girolami A; Scandellari R; Scapin M; Vettore S Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200 [TBL] [Abstract][Full Text] [Related]
9. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Nielsen VG; Cohen BM; Cohen E Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625 [TBL] [Abstract][Full Text] [Related]
10. Factor IX-Padua enhances the fibrinolytic resistance of plasma clots. Ammollo CT; Semeraro F; Colucci M; Simioni P Thromb Haemost; 2014 Feb; 111(2):226-32. PubMed ID: 24136406 [TBL] [Abstract][Full Text] [Related]
11. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders. Dahlbäck B Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771 [TBL] [Abstract][Full Text] [Related]
12. Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed. Girolami A; Ferrari S; Cosi E; Girolami B; Lombardi AM Hematology; 2018 Mar; 23(2):105-110. PubMed ID: 28762299 [TBL] [Abstract][Full Text] [Related]
14. Incorporation of the factor IX Padua mutation into FIX-Triple improves clotting activity in vitro and in vivo. Kao CY; Yang SJ; Tao MH; Jeng YM; Yu IS; Lin SW Thromb Haemost; 2013 Aug; 110(2):244-56. PubMed ID: 23676890 [TBL] [Abstract][Full Text] [Related]
15. Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders. Girolami A; Cosi E; Ferrari S; Lombardi A; Fabris F Clin Appl Thromb Hemost; 2018 May; 24(4):560-565. PubMed ID: 28774197 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary embolism in congenital bleeding disorders: intriguing discrepancies among different clotting factors deficiencies. Girolami A; Cosi E; Tasinato V; Peroni E; Girolami B; Lombardi AM Blood Coagul Fibrinolysis; 2016 Jul; 27(5):517-25. PubMed ID: 26829362 [TBL] [Abstract][Full Text] [Related]
18. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII. Girolami A; Cosi E; Santarossa C; Ferrari S; Luigia Randi M Semin Thromb Hemost; 2015 Jun; 41(4):366-73. PubMed ID: 25973586 [TBL] [Abstract][Full Text] [Related]
19. Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations. Bauer KA; Humphries S; Smillie B; Li L; Cooper JA; Barzegar S; Rosenberg RD; Miller GJ Thromb Haemost; 2000 Sep; 84(3):396-400. PubMed ID: 11019961 [TBL] [Abstract][Full Text] [Related]
20. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles. Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]